ClinicalTrials.Veeva

Menu
A

Adams Clinical | Philadelphia, PA

Research site

Site insights

Top conditions

Top treatments

MM120
Brenipatide
LSD D-Tartrate
CYB003
Centanafadine
GATE-251
KarXT

Parent organization

This site is a part of Adams Clinical

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Active trials

8 of 9 total trials

A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder (GATE-251)

The goal of this clinical trial is to learn if zelquistinel works to treat depression in adults. It will also learn about the safety of zelquistinel....

Enrolling
Major Depressive Disorder
Drug: Zelquistinel

A Phase 3 Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating MM120 Compared to Placebo in Generalized A...

Enrolling
Generalized Anxiety Disorder
Drug: MM120 (LSD D-Tartrate)
Other: Placebo

A Phase 3 Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating MM120 Compared to Placebo in Major Depress...

Active, not recruiting
Major Depressive Disorder
Other: Placebo
Drug: MM120 (LSD D-Tartrate)

The purpose of this study is to determine the efficacy, safety and tolerability of CYB003 compared to matching placebo as adjunctive treatment in pat...

Enrolling
Depression in Adults
Depression Disorders
Drug: CYB003
Behavioral: Psychological Support

The purpose of this study is to assess the efficacy and safety of brenipatide when administered with standard of care (SoC) compared to placebo plus...

Enrolling
Schizophrenia
Drug: Placebo
Drug: Brenipatide

The purpose of this study is to see if brenipatide, when compared to placebo, is safe and effective for participants with opioid use disorder, when u...

Enrolling
Opioid Use Disorder
Drug: Brenipatide
Drug: Buprenorphine

The purpose of this study is to characterize the effect of KarXT on voiding dynamics and urological safety in participants with DSM-5 schizophrenia.

Enrolling
Schizophrenia
Drug: Xanomeline/trospium chloride
Status recently updated

Primary: To evaluate the efficacy of CTN in adults ages with ADHD and comorbid anxiety (AISRS) Key Secondary: To assess the efficacy of CTN in adults...

Enrolling
Active, not recruiting
Social Anxiety Disorder
Anxiety
Other: Placebo
Drug: Centanafadine

Trial sponsors

Lilly logo
D
Bristol-Myers Squibb (BMS) logo
C
Janssen (J&J Innovative Medicine) logo
Otsuka logo
S

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems